Scotiabank Maintains Sector Outperform on AbbVie, Raises Price Target to $320

Benzinga Newsdesk www.benzinga.com Positive 90.9%

Neg 0% Neu 0% Pos 90.9%

Scotiabank analyst Louise Chen maintains AbbVie (NYSE:ABBV) with a Sector Outperform and raises the price target from $280 to $320.